On August 9, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a new way of administering the Jynneos vaccine for those at high risk for monkeypox infection. The EUA allows healthcare providers to use the vaccine by intradermal injection for individuals 18 years …continue reading
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be …continue reading
The U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) is reminding the public to think about health and safety in the kitchen for National Food Safety Education Month this September. Consumers are encouraged to practice behaviors that will continue to help keep them and their loved ones …continue reading
TherOx, Inc., a privately held medical device company focused on improving treatment of acute myocardial infarction (AMI), announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its SuperSaturated Oxygen (SSO2) Therapy. SSO2 Therapy provides interventional cardiologists with the first and only FDA-approved treatment beyond percutaneous coronary …continue reading